PFE Earnings

Quarterly EPS
$0.79
Q3 2024
$0.07
Q4 2024
$0.52
Q1 2025
$0.51
Q2 2025
$0.62
Q3 2025
$-0.29
Q4 2025
$0.47
Q1 2026
$-0.04
Q2 2026
Latest Revenue15.0B
Latest Net Income-238000000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.0415.0B-238000000+2.6%-107.8%
Q1 2026$0.4714.4B2.7B+5.4%-9.6%
Q4 2025-$0.2917.6B-1640000000-1.2%-514.3%
Q3 2025$0.6216.7B3.5B-5.9%-21.5%
Q2 2025$0.5114.7B2.9B+10.3%+5,000.0%
Q1 2025$0.5213.7B3.0B-7.8%-5.5%
Q4 2024$0.0717.8B418.0M+21.9%+111.7%
Q3 2024$0.7917.7B4.5B+31.2%+288.1%
Q2 2024$0.0113.3B48.0M
Q1 2024$0.5514.9B3.1B
Q4 2023-$0.6014.6B-3360000000
Q3 2023-$0.4213.5B-2376000000
Pfizer (PFE) — Earnings